Amgen Doubles Down On AI, Genomic Investments In R&D

New Tech, R&D Heads ‘Joined At The Hip’

 
• By Mandy Jackson
  
Concept of artificial intelligence. Digital, communication, science, networks
Amgen is using artificial intelligence to search genomic data for new drug targets, among other uses • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from AI

More from Digital Technologies